Liraglutide

Saxenda has weight-management labeling for specified adults and adolescents. Victoza has type 2 diabetes labeling and a cardiovascular risk-reduction indication in a specified adult population. Current product labeling matters more than a category name such as a weight-loss injection. ^{2, 3}

The labels contain thyroid C-cell tumor warnings and restrictions for medullary thyroid cancer or MEN2 history. Digestive symptoms, pancreatitis, gallbladder disease and dehydration-related kidney problems require discussion. Tell the prescriber about pregnancy, severe stomach-emptying problems and other glucose-lowering medicines. ^{1, 2, 3}

Liraglutide is not semaglutide or tirzepatide. A previous prescription for another incretin medicine does not determine eligibility or a switching schedule. Keep the carton or pharmacy label available when discussing a change, particularly if a brand or manufacturer changes.

An ingredient name is not a product approval. A compounded liraglutide vial does not inherit Saxenda or Victoza approval, device testing or labeled instructions. If compounding is proposed for an individual medical need, ask the prescriber and pharmacist to identify the ingredient, concentration, route and pharmacy in writing. Instructions should connect the prescribed amount to the supplied device. Do not reuse a pen schedule, syringe marking or storage rule from another GLP-1 medicine. ^{1, 2, 3}

A useful follow-up reviews digestive effects, hydration, nutrition, glucose readings when relevant, and all other glucose-lowering medicines. Insulin and sulfonylureas may increase low-glucose risk. The clinician should know about kidney disease, gallbladder disease, prior pancreatitis, severe stomach-emptying problems and pregnancy plans. Because liraglutide products are used daily, a missed use or interruption needs product-specific advice; do not restart at a remembered setting or copy another person's plan. ^{1, 2, 3}

Severe abdominal pain that persists, with or without vomiting, requires prompt assessment. Repeated vomiting or diarrhea can cause dehydration and kidney injury. Seek emergency care for breathing difficulty, swelling of the face or throat, fainting or another severe allergic reaction. A racing heartbeat, major mood change, neck lump, persistent hoarseness or swallowing difficulty also warrants clinical attention. Bring the exact pen or package and medication list so the team can identify the product involved. ^{1, 2, 3}

A liraglutide pen is for one person even when the needle is changed. Use a new needle as directed, remove it after use, and place it in an appropriate sharps container. Never withdraw medicine from a pen with a syringe or share a pen. If the solution looks abnormal, the pen was frozen, or storage limits were exceeded, ask the pharmacist whether it can still be used. ^{2, 3}